Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.赞助的临床试验
总计271个结果
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘淋巴瘤 | 急性髓性白血病 | 多发性骨髓瘤
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动,不招人
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止Relapsed Cutaneous T Cell Lymphom中国
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知